AMCP 2024
April 15–18, 2024 | New Orleans, LA
April 2024
AMCP brings together more than 3,000 Managed Care Pharmacy Professionals and other stakeholders to learn about cutting-edge research, discover emerging trends, and gain key insights into the future of managed care pharmacy.
See the latest managed care pharmacy research from Carelon Research at AMCP 2024. Registration is required to view presentation. For more information, go to amcpannual.org .
Carelon Research authors are indicated in bold.
Presentation |
Session |
Title |
Authors |
Affiliations |
---|---|---|---|---|
Poster Presentation Wednesday, April 17, 2024 Bronze medal winning abstract |
AMCP Poster Session |
[L4] Does ruxolitinib cream reduce corticosteroid and biologic use in patients with a history of moderate to severe atopic dermatitis? |
Liu J1, Desai K2, Teng CC2, Gandhi M1, Stockbower G2, Sturm D11 |
1Incyte Corporation, Wilmington, DE, USA, 2Carelon Research, Wilmington, DE, USA |
Poster Presentation Wednesday, April 17, 2024 |
AMCP Poster Session |
[J3] Incidence of COVID-19, associated healthcare resource utilization, and costs in patients receiving immunosuppressive therapies in a commercially insured/Medicare Advantage population |
Ketkar A1, Willey V1, Glasser L2, Dobie C3, Wenziger C1, Teng CC1, Bocage C1, Dube C2, Hirpara S2, Cunningham D4, Verduzco-Gutierrez M5 |
1Carelon Research, Wilmington, DE, USA, 22AstraZenenca, Biopharmaceuticals Medical, Wilmington, DE, USA, 3Xcenda, a Cencora Company, Conshohocken, PA, USA, 4Henry Ford Health, Detroit, MI, USA, 5UT Health San Antonio, San Antonio, TX, USA |